In recent years, the anatomic and functional contiguity of epicardial adipose tissue (EAT) to myocardium and coronary arteries has gained increasing interest for its potential pathogenetic role in obesity-related cardiac diseases. Besides its known and attributed biochemical cardioprotective properties, it is becoming evident that, in metabolic disease states, EAT-secreted bioactive molecules may play an important role in the pathogenesis of coronary artery disease and cardiac arrhythmias. EAT-derived inflammatory cytokines and reactive oxidative species may, indeed, play a part in the development of a local proatherogenic milieu by paracrine and vasocrine mechanisms of interaction. In addition, initial clinical and in vitro studies have pointed out that EAT could be a determinant of the substrate of atrial fibrillation by contributing to the structural and electrical remodeling of myocardium. This article reviews the current state of knowledge on the association of EAT with cardiac dysfunction and the potential factors mediating the cross talk between this fat depot and the underlying cardiac structures.

Guglielmi, V., Sbraccia, P. (2017). Epicardial adipose tissue: at the heart of the obesity complications. ACTA DIABETOLOGICA, 54(9), 805-812 [10.1007/s00592-017-1020-z].

Epicardial adipose tissue: at the heart of the obesity complications

Guglielmi, V;SBRACCIA, PAOLO
2017-01-01

Abstract

In recent years, the anatomic and functional contiguity of epicardial adipose tissue (EAT) to myocardium and coronary arteries has gained increasing interest for its potential pathogenetic role in obesity-related cardiac diseases. Besides its known and attributed biochemical cardioprotective properties, it is becoming evident that, in metabolic disease states, EAT-secreted bioactive molecules may play an important role in the pathogenesis of coronary artery disease and cardiac arrhythmias. EAT-derived inflammatory cytokines and reactive oxidative species may, indeed, play a part in the development of a local proatherogenic milieu by paracrine and vasocrine mechanisms of interaction. In addition, initial clinical and in vitro studies have pointed out that EAT could be a determinant of the substrate of atrial fibrillation by contributing to the structural and electrical remodeling of myocardium. This article reviews the current state of knowledge on the association of EAT with cardiac dysfunction and the potential factors mediating the cross talk between this fat depot and the underlying cardiac structures.
2017
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/09 - MEDICINA INTERNA
English
Atrial fibrillation; Coronary artery disease; Ectopic fat depots; Epicardial adipose tissue; Obesity
Guglielmi, V., Sbraccia, P. (2017). Epicardial adipose tissue: at the heart of the obesity complications. ACTA DIABETOLOGICA, 54(9), 805-812 [10.1007/s00592-017-1020-z].
Guglielmi, V; Sbraccia, P
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Rev EAT Acta Diabetologica 2017.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 652.04 kB
Formato Adobe PDF
652.04 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/186348
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 32
social impact